Related Experiment Videos
[Gene therapy in heart diseases].
F C Tanner1, T Largiadèr, Z Yang
1Universitätsspital Zürich.
Schweizerische Medizinische Wochenschrift
|December 22, 1999
Summary
Molecular cardiology advances cardiovascular disease diagnosis and treatment by identifying genetic mutations for personalized risk assessment and potential cures. This field offers new therapeutic strategies beyond traditional methods.
Area of Science:
- Molecular Cardiology
- Genetics
- Cardiovascular Disease Pathogenesis
Context:
- Cardiovascular diseases are leading causes of death and hospitalization globally.
- Current treatments offer transient effectiveness or require lifelong medication.
- Understanding molecular mechanisms is crucial for advancing cardiovascular care.
Purpose:
- To explore the application of molecular biology in diagnosing and treating cardiovascular diseases.
- To investigate genetic basis of cardiac conditions like hypertrophic cardiomyopathy and long QT syndrome.
- To understand the molecular pathogenesis of atherosclerosis and restenosis.
Summary:
- Molecular cardiology enables precise diagnosis of monogenetic cardiovascular diseases through genetic mutation identification, allowing for better prognostic evaluation and risk stratification.
- Research has elucidated molecular and cellular changes in atherosclerosis, leading to new therapeutic insights, though genetic intervention remains complex.
- Gene therapy is being explored for conditions like restenosis and coronary bypass graft disease, with a focus on angiogenesis and vascular endothelial growth factor.
Impact:
- Improved diagnostic accuracy and personalized risk assessment for inherited cardiac conditions.
- Development of novel therapeutic strategies targeting molecular pathways in cardiovascular diseases.
- Potential for curative genetic therapies for specific cardiovascular disorders.